PolyNovo

Aging Populations And Rising Diabetes Will Expand Advanced Wound Care

AnalystHighTarget

Not Invested

Consensus Narrative from 9 Analysts

Published

30 Jul 25

Updated

09 Aug 25

AnalystHighTarget's Fair Value

AU$2.60

55.4% undervalued

09 Aug

AU$1.16

-54.3%

-2.5%

Author's Valuation

AU$2.6

55.4% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

AU$2.6

55.4% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

14.67%

Medical Equipment revenue growth rate

0.31%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.15%

Calculation

AU$30.98m

Earnings '28

71.44x

PE Ratio '28

AU$2.21b

Market Cap '28

AU$2.21b

Market Cap '28

692.68m

No. shares '28

AU$3.19

Share Price '28

AU$3.19 Share Price '28

Discounted to 2025 @ 7.14% p.a.

AU$2.60

Fair Value '25